Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy

• Status: Not yet recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to compare the effect of the concentration of vasopressin, which is used as a method for reducing blood loss in robot-assisted laparoscopic myomectomy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Collaborator: CHA University
• Treatments: Arginine Vasopressin; Vasopressins

Criteria

Inclusion Criteria:

• Informed consent

• Age: 19-60 year-old women

• Plan of myomectomy for uterine leiomyomas

• Leiomyoma Subclassification System 2-7 (robot-assisted laparoscopic myomectomy is possible)

• American Society of Anesthesiologists Physical Status classification 1 or 2

• A person who understands the contents of the clinical trial, is cooperative with the trial, and is judged to be able to participate until the end of the study

Exclusion Criteria:

• Pregnancy or breastfeeding

• A single diameter of uterine leiomyoma is greater than 12 cm or more or multiple leiomyomas with more than five

• Suspicious disease of uterine malignancy

• Patient with has a history of pelvic surgery (cesarean section, myomectomy, etc.) and is expected to have severe pelvic adhesion

• A person who is hypersensitive or contraindicated to vasopressin

• A person who is hypersensitive or contraindicated to tranexamic acid

• Considered as inappropriate by the researcher's judgment